Cancer Drugs Approved Based on Biomarkers and Not Tumor Type-FDA Approval of Pembrolizumab for Mismatch Repair-Deficient Solid Cancers
| Image |  |
|---|---|
| Description | scientific article published on 28 December 2017 |
| Author/s |
author: Sham Mailankody |
| Publication date | December 28, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |